Anemia of inflammation

Weiss, 2005, Anemia of chronic disease, N Engl J Med, 352, 1011, 10.1056/NEJMra041809 Kassebaum, 2014, A systematic analysis of global anemia burden from 1990 to 2010, Blood, 123, 615, 10.1182/blood-2013-06-508325 Steinbicker, 2013, Out of balance–systemic iron homeostasis in iron-related disorders, Nutrients, 5, 3034, 10.3390/nu5083034 Macciò, 2015, The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study, Haematologica, 100, 124, 10.3324/haematol.2014.112813 Weiss, 2013, Anaemia in inflammatory rheumatic diseases, Nat Rev Rheumatol, 9, 205, 10.1038/nrrheum.2012.183 Tim Goodnough, 2017, Management of anemia in patients with congestive heart failure, Am J Hematol, 92, 88, 10.1002/ajh.24595 Anker, 2009, Ferric carboxymaltose in patients with heart failure and iron deficiency, N Engl J Med, 361, 2436, 10.1056/NEJMoa0908355 Goodnough, 2014, Evaluation and management of anemia in the elderly, Am J Hematol, 89, 88, 10.1002/ajh.23598 Stauder, 2018, Anemia at older age: etiologies, clinical implications, and management, Blood, 131, 505, 10.1182/blood-2017-07-746446 Ferrucci, 2010, Proinflammatory state, hepcidin, and anemia in older persons, Blood, 115, 3810, 10.1182/blood-2009-02-201087 Muckenthaler, 2017, A red carpet for iron metabolism, Cell, 168, 344, 10.1016/j.cell.2016.12.034 Nemeth, 2004, IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin, J Clin Invest, 113, 1271, 10.1172/JCI200420945 Canali, 2016, Activin B induces noncanonical SMAD1/5/8 signaling via BMP type i receptors in hepatocytes: evidence for a role in hepcidin induction by inflammation in male mice, Endocrinology, 157, 1146, 10.1210/en.2015-1747 Girelli, 2016, Hepcidin in the diagnosis of iron disorders, Blood, 127, 2809, 10.1182/blood-2015-12-639112 Nemeth, 2004, Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization, Science, 306, 2090, 10.1126/science.1104742 Ganz, 2012, Hepcidin and iron homeostasis, Biochim Biophys Acta, 1823, 1434, 10.1016/j.bbamcr.2012.01.014 Aschemeyer, 2018, Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin, Blood, 131, 899, 10.1182/blood-2017-05-786590 Theurl, 2006, Dysregulated monocyte iron homeostasis and erythropoietin formation in patients with anemia of chronic disease, Blood, 107, 4142, 10.1182/blood-2005-08-3364 Theurl, 2009, Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications, Blood, 113, 5277, 10.1182/blood-2008-12-195651 Atkinson, 2008, Tumor necrosis factor SNP haplotypes are associated with iron deficiency anemia in West African children, Blood, 112, 4276, 10.1182/blood-2008-06-162008 Nairz, 2017, “Pumping iron”-how macrophages handle iron at the systemic, microenvironmental, and cellular levels, Pflugers Arch, 469, 397, 10.1007/s00424-017-1944-8 Miyanishi, 2007, Identification of Tim4 as a phosphatidylserine receptor, Nature, 450, 435, 10.1038/nature06307 Moldawer, 1989, Cachectin/tumor necrosis factor-alpha alters red blood cell kinetics and induces anemia in vivo, FASEB J, 3, 1637, 10.1096/fasebj.3.5.2784116 Theurl, 2016, On-demand erythrocyte disposal and iron recycling requires transient macrophages in the liver, Nat Med, 22, 945, 10.1038/nm.4146 Arosio, 2015, The importance of eukaryotic ferritins in iron handling and cytoprotection, Biochem J, 472, 1, 10.1042/BJ20150787 Peyssonnaux, 2006, TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens, Blood, 107, 3727, 10.1182/blood-2005-06-2259 Theurl, 2008, Autocrine formation of hepcidin induces iron retention in human monocytes, Blood, 111, 2392, 10.1182/blood-2007-05-090019 Ludwiczek, 2003, Cytokine-mediated regulation of iron transport in human monocytic cells, Blood, 101, 4148, 10.1182/blood-2002-08-2459 Guida, 2015, A novel inflammatory pathway mediating rapid hepcidin-independent hypoferremia, Blood, 125, 2265, 10.1182/blood-2014-08-595256 Delaby, 2008, Sequential regulation of ferroportin expression after erythrophagocytosis in murine macrophages: early mRNA induction by haem, followed by iron-dependent protein expression, Biochem J, 411, 123, 10.1042/BJ20071474 Khalil, 2018, Iron modulation of erythropoiesis is associated with Scribble-mediated control of the erythropoietin receptor, J Exp Med, 215, 661, 10.1084/jem.20170396 Zhang, 2018, HRI coordinates translation by eIF2αP and mTORC1 to mitigate ineffective erythropoiesis in mice during iron deficiency, Blood, 131, 450, 10.1182/blood-2017-08-799908 Richardson, 2013, Isocitrate ameliorates anemia by suppressing the erythroid iron restriction response, J Clin Invest, 123, 3614, 10.1172/JCI68487 Cazzola, 1996, Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis, Blood, 87, 4824, 10.1182/blood.V87.11.4824.bloodjournal87114824 La Ferla, 2002, Inhibition of erythropoietin gene expression signaling involves the transcription factors GATA-2 and NF-kappaB, FASEB J, 16, 1811, 10.1096/fj.02-0168fje Jelkmann, 2011, Regulation of erythropoietin production, J Physiol, 589, 1251, 10.1113/jphysiol.2010.195057 Okonko, 2013, Erythropoietin resistance contributes to anaemia in chronic heart failure and relates to aberrant JAK-STAT signal transduction, Int J Cardiol, 164, 359, 10.1016/j.ijcard.2011.07.045 Nai, 2015, The second transferrin receptor regulates red blood cell production in mice, Blood, 125, 1170, 10.1182/blood-2014-08-596254 Kautz, 2014, Identification of erythroferrone as an erythroid regulator of iron metabolism, Nat Genet, 46, 678, 10.1038/ng.2996 Sonnweber, 2014, Hypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB, Gut, 63, 1951, 10.1136/gutjnl-2013-305317 Tanno, 2007, High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin, Nat Med, 13, 1096, 10.1038/nm1629 Silvestri, 2009, Molecular mechanisms of the defective hepcidin inhibition in TMPRSS6 mutations associated with iron-refractory iron deficiency anemia, Blood, 113, 5605, 10.1182/blood-2008-12-195594 Latour, 2017, Erythroferrone contributes to hepcidin repression in a mouse model of malarial anemia, Haematologica, 102, 60, 10.3324/haematol.2016.150227 Dallalio, 2003, Effects of oxidative stress on human erythroid colony formation: Modulation by gamma-interferon, J Lab Clin Med, 141, 395, 10.1016/S0022-2143(03)00041-6 Taniguchi, 1997, Interferon gamma downregulates stem cell factor and erythropoietin receptors but not insulin-like growth factor-I receptors in human erythroid colony-forming cells, Blood, 90, 2244, 10.1182/blood.V90.6.2244 Libregts, 2011, Chronic IFN-γ production in mice induces anemia by reducing erythrocyte life span and inhibiting erythropoiesis through an IRF-1/PU.1 axis, Blood, 118, 2578, 10.1182/blood-2010-10-315218 Mitlyng, 2006, Use of breath carbon monoxide measurements to assess erythrocyte survival in subjects with chronic diseases, Am J Hematol, 81, 432, 10.1002/ajh.20644 Docherty, 2018, Best practice in critical care: anaemia in acute and critical illness, Transfus Med, 28, 181, 10.1111/tme.12505 Fretham, 2011, The role of iron in learning and memory, Adv Nutr, 2, 112, 10.3945/an.110.000190 Camaschella, 2015, Iron-deficiency anemia, N Engl J Med, 372, 1832, 10.1056/NEJMra1401038 Richardson, 2010, Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol, Proc Natl Acad Sci USA, 107, 10775, 10.1073/pnas.0912925107 Oexle, 1999, Iron-dependent changes in cellular energy metabolism: influence on citric acid cycle and oxidative phosphorylation, Biochim Biophys Acta, 1413, 99, 10.1016/S0005-2728(99)00088-2 Sharma, 2016, Intravenous iron therapy in non-anemic iron-deficient menstruating adolescent females with fatigue, Am J Hematol, 91, 973, 10.1002/ajh.24461 Bacchetta, 2014, Suppression of iron-regulatory hepcidin by vitamin D, J Am Soc Nephrol, 25, 564, 10.1681/ASN.2013040355 Perlstein, 2011, Prevalence of 25-hydroxyvitamin D deficiency in subgroups of elderly persons with anemia: association with anemia of inflammation, Blood, 117, 2800, 10.1182/blood-2010-09-309708 Knovich, 2009, Ferritin for the clinician, Blood Rev, 23, 95, 10.1016/j.blre.2008.08.001 Cohen, 2010, Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway, Blood, 116, 1574, 10.1182/blood-2009-11-253815 Thomas, 2005, Anemia of chronic disease: pathophysiology and laboratory diagnosis, Lab Hematol, 11, 14, 10.1532/LH96.04049 Goodnough, 2010, Detection, evaluation, and management of iron-restricted erythropoiesis, Blood, 116, 4754, 10.1182/blood-2010-05-286260 Goodnough, 2012, Iron deficiency syndromes and iron-restricted erythropoiesis (CME), Transfusion, 52, 1584, 10.1111/j.1537-2995.2011.03495.x Bergamaschi, Pathogenesis, diagnosis and treatment of anaemia in immune-mediated gastrointestinal disorders, Br J Haematol Cappellini, 2017, Iron deficiency across chronic inflammatory conditions: international expert opinion on definition, diagnosis, and management, Am J Hematol, 92, 1068, 10.1002/ajh.24820 Nielsen, 2018, Rational management of iron-deficiency anaemia in inflammatory bowel disease, Nutrients, 10, E82, 10.3390/nu10010082 Punnonen, 1997, Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency, Blood, 89, 1052, 10.1182/blood.V89.3.1052 van Santen, 2014, Hematologic parameters predicting a response to oral iron therapy in chronic inflammation, Haematologica, 99, e171, 10.3324/haematol.2014.106799 Torino, 2015, Evaluation of erythrocyte and reticulocyte parameters as indicative of iron deficiency in patients with anemia of chronic disease, Rev Bras Hematol Hemoter, 37, 77, 10.1016/j.bjhh.2015.02.004 Wish, 2018, Positive iron balance in chronic kidney disease: how much is too much and how to tell?, Am J Nephrol, 47, 72, 10.1159/000486968 Goodnough, 2000, Erythropoietin, iron, and erythropoiesis, Blood, 96, 823, 10.1182/blood.V96.3.823 Weiss, 2015, Anemia of chronic disorders: new diagnostic tools and new treatment strategies, Semin Hematol, 52, 313, 10.1053/j.seminhematol.2015.07.004 Busti, 2014, Iron deficiency in the elderly population, revisited in the hepcidin era, Front Pharmacol, 5, 83, 10.3389/fphar.2014.00083 van Santen, 2011, Hepcidin and hemoglobin content parameters in the diagnosis of iron deficiency in rheumatoid arthritis patients with anemia, Arthritis Rheum, 63, 3672, 10.1002/art.30623 Lasocki, 2008, Phlebotomies or erythropoietin injections allow mobilization of iron stores in a mouse model mimicking intensive care anemia, Crit Care Med, 36, 2388, 10.1097/CCM.0b013e31818103b9 Theurl, 2011, Pathways for the regulation of hepcidin expression in anemia of chronic disease and iron deficiency anemia in vivo, Haematologica, 96, 1761, 10.3324/haematol.2011.048926 Thomas, 2011, Serum hepcidin-25 in comparison to biochemical markers and hematological indices for the differentiation of iron-restricted erythropoiesis, Clin Chem Lab Med, 49, 207, 10.1515/CCLM.2011.056 Bregman, 2013, Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia, Am J Hematol, 88, 97, 10.1002/ajh.23354 Soares, 2015, The iron age of host-microbe interactions, EMBO Rep, 16, 1482, 10.15252/embr.201540558 Ganz, 2015, Iron homeostasis in host defence and inflammation, Nat Rev Immunol, 15, 500, 10.1038/nri3863 Nairz, 2013, Nitric oxide-mediated regulation of ferroportin-1 controls macrophage iron homeostasis and immune function in Salmonella infection, J Exp Med, 210, 855, 10.1084/jem.20121946 Stefanova, 2017, Endogenous hepcidin and its agonist mediate resistance to selected infections by clearing non-transferrin-bound iron, Blood, 130, 245, 10.1182/blood-2017-03-772715 Drakesmith, 2012, Hepcidin and the iron-infection axis, Science, 338, 768, 10.1126/science.1224577 Gwamaka, 2012, Iron deficiency protects against severe Plasmodium falciparum malaria and death in young children, Clin Infect Dis, 54, 1137, 10.1093/cid/cis010 Sazawal, 2006, Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial, Lancet, 367, 133, 10.1016/S0140-6736(06)67962-2 Soofi, 2013, Effect of provision of daily zinc and iron with several micronutrients on growth and morbidity among young children in Pakistan: a cluster-randomised trial, Lancet, 382, 29, 10.1016/S0140-6736(13)60437-7 Prentice, 2013, Iron fortification and malaria risk in children, JAMA, 310, 914, 10.1001/jama.2013.6771 Prentice, 2012, Hepcidin is the major predictor of erythrocyte iron incorporation in anemic African children, Blood, 119, 1922, 10.1182/blood-2011-11-391219 Murphy, 2017, Blood transfusion strategies in elderly patients, Lancet Haematol, 4, e453, 10.1016/S2352-3026(17)30173-4 Villanueva, 2013, Transfusion strategies for acute upper gastrointestinal bleeding, N Engl J Med, 368, 11, 10.1056/NEJMoa1211801 Goodnough, 2014, Do liberal blood transfusions cause more harm than good?, BMJ, 349, g6897, 10.1136/bmj.g6897 Koutroubakis, 2015, The influence of anti-tumor necrosis factor agents on hemoglobin levels of patients with inflammatory bowel disease, Inflamm Bowel Dis, 21, 1587, 10.1097/MIB.0000000000000417 Papadaki, 2002, Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-alpha antibody therapy, Blood, 100, 474, 10.1182/blood-2002-01-0136 Goodnough, 2013, Current status of pharmacologic therapies in patient blood management, Anesth Analg, 116, 15, 10.1213/ANE.0b013e318273f4ae Tonia, 2012, Erythropoietin or darbepoetin for patients with cancer, Cochrane Database Syst Rev, 12, CD003407 Solomon, 2010, Erythropoietic response and outcomes in kidney disease and type 2 diabetes, N Engl J Med, 363, 1146, 10.1056/NEJMoa1005109 Macdougall, 2013, Peginesatide for anemia in patients with chronic kidney disease not receiving dialysis, N Engl J Med, 368, 320, 10.1056/NEJMoa1203166 Jelkmann, 2008, The erythropoietin receptor in normal and cancer tissues, Crit Rev Oncol Hematol, 67, 39, 10.1016/j.critrevonc.2008.03.006 Nairz, 2011, Erythropoietin contrastingly affects bacterial infection and experimental colitis by inhibiting nuclear factor-κB-inducible immune pathways, Immunity, 34, 61, 10.1016/j.immuni.2011.01.002 Reinisch, 2013, A randomized, open-label, non-inferiority study of intravenous iron isomaltoside 1,000 (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED), Am J Gastroenterol, 108, 1877, 10.1038/ajg.2013.335 Macdougall, 2014, FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia, Nephrol Dial Transplant, 29, 2075, 10.1093/ndt/gfu201 Muñoz, 2017, Current misconceptions in diagnosis and management of iron deficiency, Blood Transfus, 15, 422 Girelli, 2018, Modern iron replacement therapy: clinical and pathophysiological insights, Int J Hematol, 107, 16, 10.1007/s12185-017-2373-3 Moretti, 2015, Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women, Blood, 126, 1981, 10.1182/blood-2015-05-642223 Wysowski, 2010, Use of parenteral iron products and serious anaphylactic-type reactions, Am J Hematol, 85, 650, 10.1002/ajh.21794 Rampton, 2014, Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management, Haematologica, 99, 1671, 10.3324/haematol.2014.111492 Koskenkorva-Frank, 2013, The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: insights into the potential of various iron therapies to induce oxidative and nitrosative stress, Free Radic Biol Med, 65, 1174, 10.1016/j.freeradbiomed.2013.09.001 Sebastiani, 2016, Pharmacological targeting of the hepcidin/ferroportin axis, Front Pharmacol, 7, 160, 10.3389/fphar.2016.00160 Akchurin, 2016, Lack of hepcidin ameliorates anemia and improves growth in an adenine-induced mouse model of chronic kidney disease, Am J Physiol Renal Physiol, 311, F877, 10.1152/ajprenal.00089.2016 Theurl, 2014, Hepcidin as a predictive factor and therapeutic target in erythropoiesis-stimulating agent treatment for anemia of chronic disease in rats, Haematologica, 99, 1516, 10.3324/haematol.2013.099481 Haase, 2017, Therapeutic targeting of the HIF oxygen-sensing pathway: lessons learned from clinical studies, Exp Cell Res, 356, 160, 10.1016/j.yexcr.2017.05.004 Tanaka, 2018, HIF activation against CVD in CKD: novel treatment opportunities, Semin Nephrol, 38, 267, 10.1016/j.semnephrol.2018.02.006